Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News UNITY Biotechnology Inc UBX

Healthcare Biotechnology
Unity Biotechnology, Inc. is engaged in developing therapeutics to slow, halt, or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells. The Company is also focused on advancing senolytic programs primarily in ophthalmologic disorders. It is also focused on advancing other programs based on other biologies of aging to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:UBX)

UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME

GlobeNewswire 1 day ago

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

GlobeNewswire 9 days ago

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

GlobeNewswire February 6, 2024

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME

GlobeNewswire December 12, 2023

UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates

GlobeNewswire November 13, 2023

UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds

GlobeNewswire November 10, 2023

UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration

GlobeNewswire September 27, 2023

UNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business Updates

GlobeNewswire August 8, 2023

UNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME)

GlobeNewswire June 21, 2023
View More News ››

Opinion & Analysis (NDAQ:UBX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:UBX)

RE:Soon a BLOW!!!

Will go to the moon after the aug17 announcemt
north40 - August 10, 2020

Soon a BLOW!!!

Load Up !!!
Kiritman - July 10, 2020

Stock Gumshoe says

 "The Penny Stock Letter" is pumping  UBX. Appears to have been doing so since $6.00 But running out of steam at $7...
AnalogueMan - October 21, 2019
View more Bullboard ››

Delphx Capital Markets Inc.

Delphx Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of ...
View More »